Lucida Medical
Lucida Medical is a company specializing in AI-driven solutions for prostate cancer diagnosis and pathway optimization. Their flagship product, Pi™, is an AI software that assists physicians in detecting and diagnosing prostate cancer using MRI scans. Pi™ has demonstrated accuracy comparable to expert radiologists, with studies showing 95% sensitivity and 67% specificity. The company's mission is to advance the prostate cancer pathway by supporting physicians, reducing healthcare costs, and improving patient care. Lucida Medical collaborates with numerous partners, including Sectra, Blackford, and TeraRecon, to integrate Pi™ into existing healthcare systems and make it widely accessible. They are also backed by investors such as Macmillan Cancer Support.
Lucida Medical
Lucida Medical is a company specializing in AI-driven solutions for prostate cancer diagnosis and pathway optimization. Their flagship product, Pi™, is an AI software that assists physicians in detecting and diagnosing prostate cancer using MRI scans. Pi™ has demonstrated accuracy comparable to expert radiologists, with studies showing 95% sensitivity and 67% specificity. The company's mission is to advance the prostate cancer pathway by supporting physicians, reducing healthcare costs, and improving patient care. Lucida Medical collaborates with numerous partners, including Sectra, Blackford, and TeraRecon, to integrate Pi™ into existing healthcare systems and make it widely accessible. They are also backed by investors such as Macmillan Cancer Support.